PharmiWeb.com - Global Pharma News & Resources
04-Feb-2019

The Worldwide Market for Regenerative Medicine (2019-2024) by Type of Product, Therapy and Application - The Increasing Adoption of Stem Cell Technology is a Key Driver - ResearchAndMarkets.com

The "Regenerative Medicine Market - Segmented by Type of Products, Therapy and Applications (Bone Graft Substitutes, Osteoarticular Diseases, Dermatology, Cardiovascular, Central Nervous System) - Growth, Trends and Forecasts (2019-2024)" report has been added to ResearchAndMarkets.com's offering.

The global regenerative medicine market has been estimated to reach USD 4.23 billion in 2023. The market is expected to register a CAGR of 14% during the forecast period, 2018 to 2023. Currently, North America dominates the market due to rapid technological advancements.

Increasing Adoption of Stem Cell Technology

Increasing adoption of stem cell technology, growing prevalence of chronic diseases, and emerging applications of gene therapy in regenerative medicine are some of the driving factors for the global regenerative medicine market. Technological advances in regenerative medicine (stem cell, tissue engineering, and nanotechnology) and high investment & funding to support development of regenerative medicine are also fuelling market growth.

Regulatory & Ethical Issues

Regulatory and ethical issues pertaining to stem cell, tissue engineering, and regenerative medicine are acting as a restraint for the regenerative medicine market. High cost of treatments and less awareness about regenerative medicine among people are further limiting the market.

North America to Dominate the Regenerative Medicine Market

North America dominates the regenerative medicine market due to rapid technological advancements and high investment & funding to support development of regenerative medicine. Asia-Pacific is also expected to propel the regenerative medicine market, owing to factors, such as increasing accessibility to healthcare facilities in the region, and surging economic growth.

Topics Covered

1. Introduction

2. Regenerative Medicine Market Research Methodology

3. Executive Summary

4. Key Inferences

5. Regenerative Medicine Market Overview

5.1 Current Market Scenario

5.2 Porter's Five Forces

6. Regenerative Medicine Market Drivers, Restraints, Opportunities and Challenges Analysis (DROC)

6.1 Regenerative Medicine Market Drivers

6.1.1 Increasing Adoption of Stem Cell Technology

6.1.2 Technological Advances in Regenerative Medicine

6.2 Regenerative Medicine Market Restraints

6.2.1 Regulatory and Ethical Issues

6.2.2 High Cost of Treatments and Less Awareness

6.3 Regenerative Medicine Market Opportunities

6.4 Key Challenges

7. Regenerative Medicine Market Segmentation

7.1 Regenerative Medicine Market By Type of Technology

7.1.1 Stem Cell Therapy

7.1.2 Biomaterial

7.1.3 Tissue Engineering

7.2 Regenerative Medicine Market By Type of Applications

7.2.1 Bone Graft Substitutes

7.2.2 Osteoarticular Diseases

7.2.3 Dermatology

7.2.4 Cardiovascular

7.2.5 Central Nervous System

7.3 Regenerative Medicine Market By Geography

7.3.1 North America Regenerative Medicine Market Size (2018-2023)

7.3.2 Europe Regenerative Medicine Market Size (2018-2023)

7.3.3 Asia-Pacific Regenerative Medicine Market Size (2018-2023)

7.3.4 Middle East & Africa Regenerative Medicine Market Size (2018-2023)

7.3.5 South America Regenerative Medicine Market Size (2018-2023)

8. Competitive Landscape

9. Regenerative Medicine Market Key Players

9.1 Acelity

9.2 Osiris Therapeutics

9.3 Integra Lifesciences Corporation

9.4 Cook Biotech Incorporated

9.5 Organogenesis Inc.

9.6 Merck & Co.

9.7 Others

10. Regenerative Medicine Market Future

For more information about this report visit https://www.researchandmarkets.com/research/2xjbmx/the_worldwide?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190204005638/en/

Editor Details

Last Updated: 04-Feb-2019